Zhongnan Medical Journal Press

Home Results

A total of 36 result was found. Results that relate to ZHANG Jin

Clinical observation of Zishen Ningxin capsule combined with telmisartan in the treatment of perimenopausal hypertension

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):52-59.
10507 times 2414 times

WANG Bei DU Mingmin WANG Chengyi FU Da ZHANG Jing WANG Qiang

Zishen Ningxin capsule Telmisartan Perimenopause Hypertension
Details
Establishment and application of drug use evaluation criteria of fibrinogenase for injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):145-151.
13309 times 2838 times

REN Ruiqin ZHANG Jing GONG Yizhen ZHANG Jinhua

Fibrinogenase for injection Drug use evaluation Standard Expert consultation Rational drug use
Details
Teriparatide treatment for osteoporosis: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):75-84.
13800 times 2874 times

LYU Peng ZHANG Jingli WAN Yuansheng HUANG Yifei YOU Ruxu

Teriparatide Osteogenesis Safety Effectiveness Economy Rapid health technology assessment
Details
Research progress on the mechanism of long non-coding RNA LINC00641 in the development of malignant tumors

Published on New Medicine 2024,34(1):88-98.
13916 times 2961 times

GUO Mengmeng MING Daojing REN Yiming QIAN Xinhang YANG Shisong WANG Congcong LU Peiwen ZHANG Jinhui YUAN Shuai XI Shu ZENG Xiantao

Long non-coding RNAs LINC00641 Malignant tumor
Details
Establishment and application of drug use evaluation criteria of argatroban

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):121-127.
9112 times 2287 times

DAI Hengfen ZHENG Caiyun LIU Yunchun ZHANG Hong LIU Maobai ZHANG Jinghua

Argatroban Drug use evaluation criteria Expert consultation method Rational drug use
Details
Drug use evaluation of ozagrel sodium based on weighted TOPSIS method

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):137-144.
9175 times 2383 times

ZHU Shanshan WANG Na CAI Huiya ZHANG Jinhua

Ozagrel sodium Drug use evaluation Weighted TOPSIS method Delphi method Rational drug use
Details
Mechanism research of PI3K/AKT pathway regulating PHF19 gene expression in prostate cancer

Published on New Medicine 2024,34(2):121-128.
13263 times 3776 times

MING Daojing GUO Mengmeng ZHANG Jinhui LIU Mengyang SHI Minghui LIU Shuyan YUAN Shuai ZENG Xiantao

PI3K/AKT TP63 PHF19 Prostate cancer
Details
Research progress of Toll-like receptors in calcified aortic valve disease

Published on New Medicine 2024,34(2):217-225.
13892 times 3722 times

REN Yiming ZHANG Jinhui WANG Congcong WANG Tiankun REN Xuequn ZHOU Jianliang

Calcified aortic valve disease Toll-like receptor The inflammatory response
Details
Analysis of volatile constituents in different parts of Huai chrysanthemum by GC-MS combined with stoichiometry

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):209-219.
10819 times 2508 times

GUO Mengzhen LI Meng DENG Xiaoyan LIU Shuyan WANG Xiaolan SUN Xiaoya ZHANG Jingke ZHENG Xiaoke FENG Weisheng

Huai chrysanthemumin Different parts Volatile oil Gas chromatography-mass spectrometry Chemometrics
Details
The expression of ASXL3 in prostate cancer

Published on New Medicine 2024,34(3):282-290.
13217 times 3517 times

ZHANG Jinhui LIU Mengyang CUI Jinlong REN Yiming CAI Yi MING Daojing REN Xuequn YUAN Shuai

ASXL3 Prostate cancer Prognosis Immune infiltration Biomarkers
Details
Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

Published on New Medicine 2024,34(4):381-390.
16777 times 3907 times

LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao

Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases
Details
Drug use evaluation of bivalirudin for injection based on weighted TOPSIS method

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):361-370.
10124 times 2551 times

LI Ruijuan LI Meijuan MI Xiaolong CHEN Weihong LI Zhihong WANG Xiaomin ZHANG Jinhua

Bivalirudin Drug use evaluation Weighted TOPSIS method Rational drug use
Details
Establishment and application of drug use evaluation criteria of recombinant human prourokinase

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):371-380.
11903 times 2986 times

ZHUANG Zhihe QIN Qin CAI Huiya MA Tianyu WANG Runqiu XIANG Qian ZHANG Jinhua

Recombinant human prourokinase Drug use evaluation Standard rules Rational drug use Adverse drug reaction
Details
Establishment and application of drug use evaluation standard of somatostatin for injection

Published on Chinese Journal of Pharmacoepidemiology 2024,33(4):381-387.
15721 times 3091 times

ZHANG Jiehong CAI Huiya CAI Liping HAN Yibo ZHANG Jinhua

Somatostatin for injection Drug use evaluation standard Rational drug use
Details
Pharmacoeconomic evaluation of aflibercept versus conbercept for the treatment of wet age-related macular degeneration

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):655-662.
14576 times 2870 times

LIU Dan ZHANG Bochao ZHANG Jing WANG Juan YUAN Yi GUI Lin CHEN Li

Wet age-related macular degeneration Aflibercept Conbercept Markov model Pharmacoeconomic analysis
Details